Prof David Thomas presents a talk on genomic testing by unlocking the potential of precision oncology for patients and for health systems as part of the ecancer 'Genomics in oncology' series.
He discusses the Cancer Molecular Screening and Therapeutics (MoST) programme and how precision oncology directs benefit.